Telmisartan Plus Tablets 40/12.5 Milligrams

Adult dose

Patients whose blood pressure is not adequately controlled with telmisartan monotherapy should take this medication once daily with water, regardless of meals. It is recommended to adjust the dosage of each component individually before administering this fixed-dose combination. If clinically appropriate, direct conversion from monotherapy to this combination may also be considered. - Telmisartan/Hydrochlorothiazide combination 4

Child dose

Safety and efficacy have not been established for children under 18 years, thus it should not be administered.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious side effects to the fetus or newborn. It is contraindicated for individuals with allergies to this medication or its excipients, hypersensitivity to sulfonamide drugs, pregnant or nursing women, patients with cholestasis or obstructive biliary diseases, severe liver or kidney impairment, acute glomerulonephritis, anuria, certain electrolyte imbalances, etc. Elderly patients, patients with hyperkalemia, those with mild to moderate liver impairment, heart valve disease, ischemic heart disease, gastrointestinal diseases, and renal artery hypertension should use this medication with extra caution. This medication can lower blood pressure, so symptoms such as dizziness, hypotension, and fainting may occur, particularly during driving or operating machinery. The hydrochlorothiazide component can cause fluid and electrolyte imbalances, leading to symptoms such as dry mouth, muscle cramps, and weakness, so regular blood tests to monitor electrolyte status are necessary. This medication can interact with other drugs; therefore, it is important to consult a doctor before taking it with lithium, potassium-sparing agents, diuretics, nonsteroidal anti-inflammatory drugs, antiarrhythmics, antidiabetics, etc., and to monitor blood pressure, kidney function, and serum potassium levels regularly. This medication should be discontinued as soon as possible during pregnancy, and it is advisable not to use it while breastfeeding. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may occur, so seeking immediate medical care is necessary for appropriate treatment. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been established. For elderly patients, there may be a risk of excessively low blood pressure leading to stroke, so careful monitoring is essential during use. When using this medication, keep it out of reach of children, and do not transfer it into other containers for safety.

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, high fever, severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reaction, shortness of breath or difficulty breathing, asthma attacks, breathing abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme fatigue, liver abnormalities (jaundice), sudden and severe

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C, avoiding excessively hot or cold places.

Appearance

White or nearly white-red, oval-shaped tablet consisting of two layers, with possible red spots on the white layer.

Package unit

30 tablets/bottle